Skip to main content
. 2021 Aug 20;9(8):1053. doi: 10.3390/biomedicines9081053
AA arachidonic acid
ACE angiotensin-converting enzyme
ACEi angiotensin-converting enzyme inhibitor
ACE2 angiotensin-converting enzyme type 2
ACF aorto-caval fistula
ANG II angiotensin II
ANG 1-7 angiotensin 1-7
AT1A angiotensin II type 1 receptor subtype A
AT2 angiotensin II type 2 receptor
CKD chronic kidney disease
CYP cytochrome P-450 enzyme
CYP2C23 cytochrome P-450 enzyme subfamily 2C23
CYP4A1 cytochrome P-450 enzyme subfamily 4A1
(+dP/dt)max maximum rates of pressure rise
(−dP/dt)max maximum rates of pressure fall
DHETEs dihydroxyeicosatrienoic acids
EET-A 14,15-epoxyeicosatrienoic acid analog
EETs epoxyeicosatrienoic acids
EDPVR end-diastolic pressure-volume relationship
ESPVR end-systolic pressure-volume relationship
FHH fawn-hooded hypertensive rats
FHL fawn-hooded low-pressure rats
GFR glomerular filtration rate
HanSD normotensive, transgene-negative, Hannover Sprague-Dawley rats
HF heart failure
IKEM Institute for Clinical and Experimental Medicine
LV left ventricle
MAP mean arterial pressure
mRNA messenger ribonucleic acid
NE norepinephrine
PRSW preload recruitable stroke work
RAS renin-angiotensin system
RBF renal blood flow
RDN renal denervation
RSNA renal sympathetic nerve activity
RV right ventricle
sEH soluble epoxide hydrolase
SHR spontaneously hypertensive rats
TGR Ren2 renin transgenic, hypertensive rats
TPR total peripheral resistance
20-HETE 20-hydroxyeicosatrienoic acid